The Natural History, Pathobiology, and Clinical Manifestations of SARS-CoV-2 Infections

Abdullah AS, Tomlinson B, Cockram CS, Thomas GN (2003) Lessons from the severe acute respiratory syndrome outbreak in Hong Kong. Emerg Infect Dis 9:1042–1045

Ahmed F, Ahmed N, Pissarides C, Stiglitz J (2020) Why inequality could spread COVID-19. Lancet Public Health 5:e240

Al Saiegh F, Ghosh R, Leibold A, Avery MB, Schmidt RF, Theofanis T, Mouchtouris N, Philipp L, Peiper SC, Wang ZX, Rincon F, Tjoumakaris SI, Jabbour P, Rosenwasser RH, Gooch MR (2020) Status of SARS-CoV-2 in cerebrospinal fluid of patients with COVID-19 and stroke. J Neurol Neurosurg Psychiatry

Angelini MM, Akhlaghpour M, Neuman BW, Buchmeier MJ (2013) Severe acute respiratory syndrome coronavirus nonstructural proteins 3, 4, and 6 induce double-membrane vesicles. mBio 4:e00524–e00513

Archer T (2020) Coronavirus cancellations and reactions in sports. ESPN. https://www.espn.com/espn/story/_/id/28871525/coronavirus-cancellations-reactions-sports

Association for Psychological Science (2020) Psychological Science and COVID-19: conspiracy theories. newswire. https://www.newswise.com/coronavirus/psychological-science-and-covid-19-conspiracy-theories/?article_id=732369

Backer JA, Klinkenberg D, Wallinga J (2020) Incubation period of 2019 novel coronavirus (2019-nCoV) infections among travellers from Wuhan, China, 20–28 January 2020. Eurosurveillance 25:2000062

Baggett TP, Keyes H, Sporn N, Gaeta JM (2020) Prevalence of SARS-CoV-2 infection in residents of a large homeless shelter in Boston. JAMA 323:2191–2192

Baig AM, Khaleeq A, Ali U, Syeda H (2020) Evidence of the COVID-19 virus targeting the CNS: tissue distribution, host-virus interaction, and proposed neurotropic mechanisms. ACS Chem Neurosci 11:995–998

Ball P, Maxmen A (2020) The epic battle against coronavirus misinformation and conspiracy theories. Nature 581:371–374

Barnes GD, Burnett A, Allen A, Blumenstein M, Clark NP, Cuker A, Dager WE, Deitelzweig SB, Ellsworth S, Garcia D, Kaatz S, Minichiello T (2020) Thromboembolism and anticoagulant therapy during the COVID-19 pandemic: interim clinical guidance from the anticoagulation forum. J Thromb Thrombolysis 50:72–81

Beigel JH et al (2020) Remdesivir for the treatment of Covid-19 - preliminary report. N Engl J Med

Bolles M, Donaldson E, Baric R (2011) SARS-CoV and emergent coronaviruses: viral determinants of interspecies transmission. Curr Opin Virol 1:624–634

Bosch BJ, van der Zee R, de Haan CA, Rottier PJ (2003) The coronavirus spike protein is a class I virus fusion protein: structural and functional characterization of the fusion core complex. J Virol 77:8801–8811

Braveman P, Gottlieb L (2014) The social determinants of health: it's time to consider the causes of the causes. Public Health Rep 129(Suppl 2):19–31

Britannica E (2020) Coronavirus: VIRUS GROUP. https://www.britannica.com/science/coronavirus-virus-group

Bruinen de Bruin Y, Lequarre AS, McCourt J, Clevestig P, Pigazzani F, Zare Jeddi M, Colosio C, Goulart M (2020) Initial impacts of global risk mitigation measures taken during the combatting of the COVID-19 pandemic. Saf Sci:104773

Cao B et al (2020) A trial of Lopinavir-ritonavir in adults hospitalized with severe Covid-19. N Engl J Med 382:1787–1799

Centers for Disease Control and Prevention (2020a) Information for Healthcare Professionals about coronavirus (COVID-19). https://www.cdc.gov/coronavirus/2019-nCoV/hcp/index.html

Centers for Disease Control and Prevention (2020b) Symptoms of coronavirus. Coronavirus Disease 2019 (COVID-19). https://www.cdc.gov/coronavirus/2019-ncov/symptoms-testing/symptoms.html

Centers for Disease Control and Prevention (2020c) What grocery and food retail workers need to know about COVID-19. https://www.cdc.gov/coronavirus/2019-ncov/community/organizations/grocery-food-retail-workers.html

Centers for Disease Control and Prevention (2020d) Considerations for Youth Sports. https://www.cdc.gov/coronavirus/2019-ncov/community/schools-childcare/youth-sports.html

Centers for Disease Control and Prevention (2020e) Funeral guidance for individuals and families. https://www.cdc.gov/coronavirus/2019-ncov/daily-life-coping/funeral-guidance.html

Centers for Disease Control and Prevention (2020f) Interim guidance for communities of faith. https://www.cdc.gov/coronavirus/2019-ncov/community/faith-based.html

Centers for Disease Control and Prevention (2020g) Coronavirus disease 2019 in children — United States, February 12–April 2, 2020. Morbid Mortal Wkly Rep 69:422–426. https://www.cdc.gov/mmwr/volumes/69/wr/mm6914e4.htm

Centers for Disease Control and Prevention (2020h) Taking care of sick people with COVID-19 illness at home. https://www.cdc.gov/coronavirus/2019-ncov/downloads/global-covid-19/A_HB_Carekit_JobAid_508C.pdf

Centers for Disease Control and Prevention (2020i) How are quarantine and isolation different? https://www.cdc.gov/coronavirus/2019-ncov/if-you-are-sick/quarantine-isolation.html

Centers for Disease Control and Prevention (2020j) COVID-19: quarantine vs. isolation. https://www.cdc.gov/coronavirus/2019-ncov/downloads/if-you-are-sick/317422-A_Quarantine-and-Isolation_508.pdf

Centers for Disease Control and Prevention (2020k) Stop the spread of germs. https://www.cdc.gov/coronavirus/2019-ncov/downloads/stop-the-spread-of-germs.pdf

Centers for Disease Control and Prevention (2020l) Implementation of mitigation strategies for communities with local COVID-19 transmission. https://www.cdc.gov/coronavirus/2019-ncov/community/community-mitigation.html

Centers for Disease Control and Prevention (2020m) CDC activities and initiatives supporting the COVID-19 response and the President’s plan for opening America up again. https://www.cdc.gov/coronavirus/2019-ncov/downloads/php/CDC-Activities-Initiatives-for-COVID-19-Response.pdf

Chen J, Qi T, Liu L, Ling Y, Qian Z, Li T, Li F, Xu Q, Zhang Y, Xu S, Song Z, Zeng Y, Shen Y, Shi Y, Zhu T, Lu H (2020a) Clinical progression of patients with COVID-19 in Shanghai, China. J Inf Secur 80:e1–e6

Chen N, Zhou M, Dong X, Qu J, Gong F, Han Y, Qiu Y, Wang J, Liu Y, Wei Y, Xia J, Yu T, Zhang X, Zhang L (2020b) Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study. Lancet 395:507–513

Chiu A (2020) Trump has no qualms about calling coronavirus the ‘Chinese Virus.’ That’s a dangerous attitude, experts say. The Washington Post. https://www.washingtonpost.com/nation/2020/03/20/coronavirus-trump-chinese-virus/

Cho SY et al (2016) MERS-CoV outbreak following a single patient exposure in an emergency room in South Korea: an epidemiological outbreak study. Lancet 388:994–1001

Chu DKW, Pan Y, Cheng SMS, Hui KPY, Krishnan P, Liu Y, Ng DYM, Wan CKC, Yang P, Wang Q, Peiris M, Poon LLM (2020) Molecular diagnosis of a Novel Coronavirus (2019-nCoV) causing an outbreak of pneumonia. Clin Chem 66:549–555

Chung K, Chik H (2020) Hong Kong police ban city’s annual Tiananmen Square vigil for first time in 30 years, citing Covid-19 threat. South China Morning Post. https://www.scmp.com/news/hong-kong/politics/article/3086982/hong-kong-police-cite-covid-19-threat-banning-annual

Coleman CM, Frieman MB (2014) Coronaviruses: important emerging human pathogens. J Virol 88:5209–5212

Cui J, Li F, Shi ZL (2019a) Origin and evolution of pathogenic coronaviruses. Nat Rev Microbiol 17:181–192

Cui J, Li F, Shi Z-L (2019b) Origin and evolution of pathogenic coronaviruses. Nat Rev Microbiol 17:181–192

de Groot RJ, Baker SC, Baric RS, Brown CS, Drosten C, Enjuanes L, Fouchier RAM, Galiano M, Gorbalenya AE, Memish ZA, Perlman S, Poon LLM, Snijder EJ, Stephens GM, Woo PCY, Zaki AM, Zambon M, Ziebuhr J (2013) Middle East respiratory syndrome coronavirus (MERS-CoV): announcement of the Coronavirus study group. J Virol 87:7790–7792

de Haan CA, de Wit M, Kuo L, Montalto-Morrison C, Haagmans BL, Weiss SR, Masters PS, Rottier PJ (2003) The glycosylation status of the murine hepatitis coronavirus M protein affects the interferogenic capacity of the virus in vitro and its ability to replicate in the liver but not the brain. Virology 312:395–406

de Wit E, van Doremalen N, Falzarano D, Munster VJ (2016) SARS and MERS: recent insights into emerging coronaviruses. Nat Rev Microbiol 14:523–534

Diao B, Wang C, Wang R, Feng Z, Tan Y, Wang H, Wang C, Liu L, Liu Y, Liu Y, Wang G, Yuan Z, Ren L, Wu Y, Chen Y (2020) Human kidney is a target for novel severe acute respiratory syndrome Coronavirus 2 (SARS-CoV-2) infection. medRxiv

Dietz L, Horve PF, Coil DA, Fretz M, Eisen JA, Van Den Wymelenberg K (2020) 2019 Novel Coronavirus (COVID-19) pandemic: built environment considerations to reduce transmission. mSystems 5:e00245–e00220

Dong E, Du H, Gardner L (2020a) An interactive web-based dashboard to track COVID-19 in real time. Lancet Infect Dis 20:533–534

Dong Y, Mo X, Hu Y, Qi X, Jiang F, Jiang Z, Tong S (2020b) Epidemiology of COVID-19 among children in China. Pediatrics 145:e20200702

Dungca N, Abelson J, Bhattarai A, Kornfield M (2020) On the front lines of the pandemic, grocery workers are in the dark about risks. The Washington Post. https://www.washingtonpost.com/investigations/2020/05/24/grocery-workers-coronavirus-risks/?arc404=true

Duong L, Xu P, Liu A (2020) Meningoencephalitis without respiratory failure in a young female patient with COVID-19 infection in downtown Los Angeles, early April 2020. Brain Behav Immun 20:30509–30502

Eliezer M, Hautefort C, Hamel AL, Verillaud B, Herman P, Houdart E, Eloit C (2020) Sudden and complete olfactory loss function as a possible symptom of COVID-19. JAMA Otolaryngol Head Neck Surg

Fazzini E, Fleming J, Fahn S (1992) Cerebrospinal fluid antibodies to coronavirus in patients with Parkinson's disease. Mov Disord 7:153–158

Federico A (2020) Brain awareness week, CoVID-19 infection and neurological sciences. Neurol Sci 41:747–748

Fehr AR, Perlman S (2015) Coronaviruses: an overview of their replication and pathogenesis. Methods Mol Biol 1282:1–23

Fong MW, Gao H, Wong JY, Xiao J, Shiu EYC, Ryu S, Cowling BJ (2020) Nonpharmaceutical measures for pandemic influenza in nonhealthcare settings-social distancing measures. Emerg Infect Dis 26:976–984

Foucault M (2005/1989) Archaeology of knowledge, 4th edn. Routledge, London

Fukushi M, Yoshinaka Y, Matsuoka Y, Hatakeyama S, Ishizaka Y, Kirikae T, Sasazuki T, Miyoshi-Akiyama T (2012) Monitoring of S protein maturation in the endoplasmic reticulum by calnexin is important for the infectivity of severe acute respiratory syndrome coronavirus. J Virol 86:11745–11753

Fung TS, Liu DX (2018) Post-translational modifications of coronavirus proteins: roles and function. Futur Virol 13:405–430

Gandhi M, Yokoe DS, Havlir DV (2020) Asymptomatic transmission, the Achilles’ heel of current strategies to control Covid-19. N Engl J Med 382:2158–2160

Gao Y et al (2020) Structure of the RNA-dependent RNA polymerase from COVID-19 virus. Science 368:779–782

Gorbalenya AE, Krupovic M, Mushegian A, et al (2020) The new scope of virus taxonomy: partitioning the virosphere into 15 hierarchical ranks. Nat Microbiol 5:668–674

Grein J et al (2020) Compassionate use of Remdesivir for patients with severe Covid-19. N Engl J Med 382:2327–2336

Grifoni A, Weiskopf D, Ramirez SI, Mateus J, Dan JM, Moderbacher CR, Rawlings SA, Sutherland A, Premkumar L, Jadi RS, Marrama D, de Silva AM, Frazier A, Carlin C, Greenbaum JA, Peters B, Krammer F, Smith DM, Crotty S, Sette A (2020) Targets of T cell responses to SARS-CoV-2 coronavirus in humans with COVID-19 disease and unexposed individuals. Cell 20:30610–30613

Gu J et al (2005) Multiple organ infection and the pathogenesis of SARS. J Exp Med 202:415–424

Guerriero RM, Pier DB, de Gusmao CM, Bernson-Leung ME, Maski KP, Urion DK, Waugh JL (2014) Increased pediatric functional neurological symptom disorders after the Boston marathon bombings: a case series. Pediatr Neurol 51:619–623

Guo T, Fan Y, Chen M, Wu X, Zhang L, He T, Wang H, Wan J, Wang X, Lu Z (2020a) Cardiovascular implications of fatal outcomes of patients with Coronavirus disease 2019 (COVID-19). JAMA Cardiol

Guo Y-R, Cao Q-D, Hong Z-S, Tan Y-Y, Chen S-D, Jin H-J, Tan K-S, Wang D-Y, Yan Y (2020b) The origin, transmission and clinical therapies on coronavirus disease 2019 (COVID-19) outbreak – an update on the status. Mil Med Res 7:11

Han DP, Lohani M, Cho MW (2007) Specific asparagine-linked glycosylation sites are critical for DC-SIGN- and L-SIGN-mediated severe acute respiratory syndrome coronavirus entry. J Virol 81:12029–12039

Helms J, Kremer S, Merdji H, Clere-Jehl R, Schenck M, Kummerlen C, Collange O, Boulay C, Fafi-Kremer S, Ohana M, Anheim M, Meziani F (2020) Neurologic features in severe SARS-CoV-2 infection. N Engl J Med 382:2268–2270

Hoffmann M, Kleine-Weber H, Schroeder S, Kruger N, Herrler T, Erichsen S, Schiergens TS, Herrler G, Wu NH, Nitsche A, Muller MA, Drosten C, Pohlmann S (2020) SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor. Cell 181:271–280

Hollander JE, Carr BG (2020) Virtually perfect? Telemedicine for Covid-19. N Engl J Med 382:1679–1681

Hon KL, Leung CW, Cheng WT, Chan PK, Chu WC, Kwan YW, Li AM, Fong NC, Ng PC, Chiu MC, Li CK, Tam JS, Fok TF (2003) Clinical presentations and outcome of severe acute respiratory syndrome in children. Lancet 361:1701–1703

Huang C et al (2020) Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet 395:497–506

Hung LS (2003) The SARS epidemic in Hong Kong: what lessons have we learned? J R Soc Med 96:374–378

Hung EC, Chim SS, Chan PK, Tong YK, Ng EK, Chiu RW, Leung CB, Sung JJ, Tam JS, Lo YM (2003) Detection of SARS coronavirus RNA in the cerebrospinal fluid of a patient with severe acute respiratory syndrome. Clin Chem 49:2108–2109

Inciardi RM, Lupi L, Zaccone G, Italia L, Raffo M, Tomasoni D, Cani DS, Cerini M, Farina D, Gavazzi E, Maroldi R, Adamo M, Ammirati E, Sinagra G, Lombardi CM, Metra M (2020) Cardiac involvement in a patient with Coronavirus disease 2019 (COVID-19). JAMA Cardiol

Irigoyen N, Firth AE, Jones JD, Chung BY, Siddell SG, Brierley I (2016) High-resolution analysis of Coronavirus gene expression by RNA sequencing and ribosome profiling. PLoS Pathog 12:e1005473

Jones VG, Mills M, Suarez D, Hogan CA, Yeh D, Bradley Segal J, Nguyen EL, Barsh GR, Maskatia S, Mathew R (2020) COVID-19 and Kawasaki disease: novel virus and novel case. Hosp Pediatr 10:537–540

Kang L, Li Y, Hu S, Chen M, Yang C, Yang BX, Wang Y, Hu J, Lai J, Ma X, Chen J, Guan L, Wang G, Ma H, Liu Z (2020a) The mental health of medical workers in Wuhan, China dealing with the 2019 novel coronavirus. Lancet Psychiatry 7:e14

Kang S, Yang M, Hong Z, Zhang L, Huang Z, Chen X, He S, Zhou Z, Zhou Z, Chen Q, Yan Y, Zhang C, Shan H, Chen S (2020b) Crystal structure of SARS-CoV-2 nucleocapsid protein RNA binding domain reveals potential unique drug targeting sites. Acta Pharm Sin B

Kelly MP, Morgan A, Bonnefoy J, Butt J, V. Bergman, World Health Organization (2007) The social determinants of health: developing an evidence base for political action. Final report of the Measurement and Evidence Knowledge Network to the World Health Organization Commission on the Social Determinants of Health

Khailany RA, Safdar M, Ozaslan M (2020) Genomic characterization of a novel SARS-CoV-2. Gene Rep:100682

Kim D, Lee JY, Yang JS, Kim JW, Kim VN, Chang H (2020) The architecture of SARS-CoV-2 transcriptome. Cell 181:914–921

Kimberlin DW, Brady MT, Jackson MA, Long SS editors (2018) American Academy of Pediatrics. Coronaviruses, Including SARS and MERS:Section 3: Summaries of Infectious Diseases - C. Red Book: 2018 Report of the Committee on Infectious Diseases American Academy of Pediatrics

Kissler SM, Tedijanto C, Goldstein E, Grad YH, Lipsitch M (2020) Projecting the transmission dynamics of SARS-CoV-2 through the postpandemic period. Science 368:860–868

Klok FA, Kruip M, van der Meer NJM, Arbous MS, Gommers D, Kant KM, Kaptein FHJ, van Paassen J, Stals MAM, Huisman MV, Endeman H (2020) Incidence of thrombotic complications in critically ill ICU patients with COVID-19. Thromb Res 191:145–147

Klumperman J, Locker JK, Meijer A, Horzinek MC, Geuze HJ, Rottier PJ (1994) Coronavirus M proteins accumulate in the Golgi complex beyond the site of virion budding. J Virol 68:6523–6534

Kollias A, Kyriakoulis KG, Dimakakos E, Poulakou G, Stergiou GS, Syrigos K (2020) Thromboembolic risk and anticoagulant therapy in COVID-19 patients: emerging evidence and call for action. Br J Haematol 189:846–847

Kono M, Tatsumi K, Imai AM, Saito K, Kuriyama T, Shirasawa H (2008) Inhibition of human coronavirus 229E infection in human epithelial lung cells (L132) by chloroquine: involvement of p38 MAPK and ERK. Antivir Res 77:150–152

Lam TTY, Shum MHH, Zhu HC, Tong YG, Ni XB, Liao YS, Wei W, Cheung WYM, Li WJ, Li LF, Leung GM, Holmes EC, Hu YL, Guan Y (2020) Identifying SARS-CoV-2 related coronaviruses in Malayan pangolins. Nature

LaMonica M (2020) Donald Trump’s ‘Chinese virus’: the politics of naming. The Conversation. https://theconversation.com/donald-trumps-chinese-virus-the-politics-of-naming-136796

Lauer SA, Grantz KH, Bi Q, Jones FK, Zheng Q, Meredith HR, Azman AS, Reich NG, Lessler J (2020) The incubation period of coronavirus disease 2019 (COVID-19) from publicly reported confirmed cases: estimation and application. Ann Int Med 172:577–582

Lefkowitz EJ, Dempsey DM, Hendrickson RC, Orton RJ, Siddell SG, Smith DB (2018) Virus taxonomy: the database of the international committee on taxonomy of viruses (ICTV). Nucleic Acids Res 46:D708–D717

Lescure FX et al (2020) Clinical and virological data of the first cases of COVID-19 in Europe: a case series. Lancet Infect Dis 20:30200

Li F (2016) Structure, function, and evolution of Coronavirus spike proteins. Annu Rev Virol 3:237–261

Li F, Li W, Farzan M, Harrison SC (2005a) Structure of SARS coronavirus spike receptor-binding domain complexed with receptor. Science 309:1864–1868

Li W, Zhang C, Sui J, Kuhn JH, Moore MJ, Luo S, Wong SK, Huang IC, Xu K, Vasilieva N, Murakami A, He Y, Marasco WA, Guan Y, Choe H, Farzan M (2005b) Receptor and viral determinants of SARS-coronavirus adaptation to human ACE2. EMBO J 24:1634–1643

Li Q et al (2020a) Early transmission dynamics in Wuhan, China, of Novel Coronavirus–infected pneumonia. N Engl J Med 382:1199–1207

Li YC, Bai WZ, Hashikawa T (2020b) The neuroinvasive potential of SARS-CoV2 may play a role in the respiratory failure of COVID-19 patients. J Med Virol 92:552–555

Lim KP, Liu DX (2001) The missing link in coronavirus assembly. Retention of the avian coronavirus infectious bronchitis virus envelope protein in the pre-Golgi compartments and physical interaction between the envelope and membrane proteins. J Biol Chem 276:17515–17523

Lim YX, Ng YL, Tam JP, Liu DX (2016) Human coronaviruses: a review of virus-host interactions. Diseases 4:26

Liu DX, Inglis SC (1991) Association of the infectious bronchitis virus 3c protein with the virion envelope. Virology 185:911–917

Liu T et al (2020) Time-varying transmission dynamics of novel coronavirus pneumonia in China. bioRxiv

Lu R et al (2020a) Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding. Lancet 395:565–574

Lu X et al (2020b) SARS-CoV-2 infection in children. N Engl J Med 382:1663–1665

Luk HKH, Li X, Fung J, Lau SKP, Woo PCY (2019) Molecular epidemiology, evolution and phylogeny of SARS coronavirus. Infect Genet Evol 71:21–30

Luo H, Chen Q, Chen J, Chen K, Shen X, Jiang H (2005) The nucleocapsid protein of SARS coronavirus has a high binding affinity to the human cellular heterogeneous nuclear ribonucleoprotein A1. FEBS Lett 579:2623–2628

Mackay IM, Arden KE (2015) MERS coronavirus: diagnostics, epidemiology and transmission. Virol J 12:222

Maier HJ, Hawes PC, Cottam EM, Mantell J, Verkade P, Monaghan P, Wileman T, Britton P (2013) Infectious bronchitis virus generates spherules from zippered endoplasmic reticulum membranes. mBio 4:e00801–e00813

Mandrola J (2020) CoViD-19 and PPE: some of us will die because of the shortage. Recenti Prog Med 111:183

Mao L, Jin H, Wang M, Hu Y, Chen S, He Q, Chang J, Hong C, Zhou Y, Wang D, Miao X, Li Y, Hu B (2020a) Neurologic manifestations of hospitalized patients with Coronavirus disease 2019 in Wuhan, China. JAMA Neurol 77:1–9

Mao R, Qiu Y, He JS, Tan JY, Li XH, Liang J, Shen J, Zhu LR, Chen Y, Iacucci M, Ng SC, Ghosh S, Chen MH (2020b) Manifestations and prognosis of gastrointestinal and liver involvement in patients with COVID-19: a systematic review and meta-analysis. Lancet Gastroenterol Hepatol 5:667–678

Marquardt K, Albertson TE (2001) Treatment of hydroxychloroquine overdose. Am J Emerg Med 19:420–424

Martinez-Rojas MA, Vega-Vega O, Bobadilla NA (2020) Is the kidney a target of SARS-CoV-2? Am J Physiol Renal Physiol 318:F1454–F1462

Masters PS (2006) The molecular biology of coronaviruses. Adv Virus Res 66:193–292

McCreary EK, Pogue JM (2020) Coronavirus disease 2019 treatment: a review of early and emerging options. Open Forum Infect Dis 7:ofaa105

Mercuro NJ, Yen CF, Shim DJ, Maher TR, McCoy CM, Zimetbaum PJ, Gold HS (2020) Risk of QT interval prolongation associated with use of hydroxychloroquine with or without concomitant azithromycin among hospitalized patients testing positive for coronavirus disease 2019 (COVID-19). JAMA Cardiol

Meselson M (2020) Droplets and aerosols in the transmission of SARS-CoV-2. N Engl J Med 382:2063

Moore BJB, June CH (2020) Cytokine release syndrome in severe COVID-19. Science 368:473–474

Morawska L, Cao J (2020) Airborne transmission of SARS-CoV-2: the world should face the reality. Environ Int 139:105730

Moriguchi T et al (2020) A first case of meningitis/encephalitis associated with SARS-Coronavirus-2. Int J Infect Dis 94:55–58

Murray RS, Brown B, Brian D, Cabirac GF (1992) Detection of coronavirus RNA and antigen in multiple sclerosis brain. Ann Neurol 31:525–533

Nakauchi M, Kariwa H, Kon Y, Yoshii K, Maeda A, Takashima I (2008) Analysis of severe acute respiratory syndrome coronavirus structural proteins in virus-like particle assembly. Microbiol Immunol 52:625–630

Nanda SK, Leibowitz JL (2001) Mitochondrial aconitase binds to the 3′ untranslated region of the mouse hepatitis virus genome. J Virol 75:3352–3362

National Center for Learning Disabilities (NCLD) (2020) COVID-19 parent resources. https://www.ncld.org/covid-19-parent-resources

Netland J, Meyerholz DK, Moore S, Cassell M, Perlman S (2008) Severe acute respiratory syndrome coronavirus infection causes neuronal death in the absence of encephalitis in mice transgenic for human ACE2. J Virol 82:7264–7275

Nicola M, Alsafi Z, Sohrabi C, Kerwan A, Al-Jabir A, Iosifidis C, Agha M, Agha R (2020) The socio-economic implications of the coronavirus and COVID-19 pandemic: a review. Int J Surg 78:185–193

Office of Disease Prevention and Health Promotion (ODPHP) (2020) Social determinants of health. https://www.healthypeople.gov/2020/topics-objectives/topic/social-determinants-of-health

Oxley TJ, Mocco J, Majidi S, Kellner CP, Shoirah H, Singh IP, De Leacy RA, Shigematsu T, Ladner TR, Yaeger KA, Skliut M, Weinberger J, Dangayach NS, Bederson JB, Tuhrim S, Fifi JT (2020) Large-vessel stroke as a presenting feature of Covid-19 in the Young. N Engl J Med 382:e60

Park MD (2020) Macrophages: a Trojan horse in COVID-19? Nat Rev Immunol 20:351

Pinto D, Windecker S, Cutlip D, Saperia G (2020) Coronavirus disease 2019 (COVID-19): myocardial infarction and other coronary artery disease issues. UpToDate

Poon DC, Ho YS, Chiu K, Wong HL, Chang RC (2015) Sickness: from the focus on cytokines, prostaglandins, and complement factors to the perspectives of neurons. Neurosci Biobehav Rev 57:30–45

Poyiadji N, Shahin G, Noujaim D, Stone M, Patel S, Griffith B (2020) COVID-19-associated acute hemorrhagic necrotizing encephalopathy: CT and MRI features. Radiology:201187

Prutkin J, Knight B, Downey B (2020) Coronavirus disease 2019 (COVID-19): arrhythmias and conduction system disease. UpToDate

Puelles VG et al (2020) Multiorgan and renal tropism of SARS-CoV-2. N Engl J Med

Pyrc K, Berkhout B, van der Hoek L (2007) The Novel human coronaviruses NL63 and HKU1. J Virol 81:3051–3057

Qinfen Z, Jinming C, Xiaojun H, Huanying Z, Jicheng H, Ling F, Kunpeng L, Jingqiang Z (2004) The life cycle of SARS coronavirus in Vero E6 cells. J Med Virol 73:332–337

Ranieri VM, Rubenfeld GD, Thompson BT, Ferguson ND, Caldwell E, Fan E, Camporota L, Slutsky AS (2012) Acute respiratory distress syndrome: the Berlin definition. JAMA 307:2526–2533

Ransom EM, Burnham C-AD, Jones L, Kraft CS, McDonald LC, Reinink AR, Young VB (2020) Fecal microbiota transplantations: where are we, where are we going, and what is the role of the clinical laboratory? Clin Chem 66:512–517

Read JM, Bridgen JR, Cummings DA, Ho A, Jewell CP (2020) Novel coronavirus 2019-nCoV: early estimation of epidemiological parameters and epidemic predictions. medRxiv

Reggiori F, Monastyrska I, Verheije MH, Cali T, Ulasli M, Bianchi S, Bernasconi R, de Haan CA, Molinari M (2010) Coronaviruses hijack the LC3-I-positive EDEMosomes, ER-derived vesicles exporting short-lived ERAD regulators, for replication. Cell Host Microbe 7:500–508

Ren LL et al (2020) Identification of a novel coronavirus causing severe pneumonia in human: a descriptive study. Chinese Med J 133:1015–1024

Rey FA, Lok SM (2018) Common features of enveloped viruses and implications for immunogen design for next-generation vaccines. Cell 172:1319–1334

Richardson S et al (2020) Presenting characteristics, comorbidities, and outcomes among 5700 patients hospitalized with COVID-19 in the New York City area. JAMA 323:2052–2059

Riou J, Althaus CL (2020) Pattern of early human-to-human transmission of Wuhan 2019 novel coronavirus (2019-nCoV), December 2019 to January 2020. Euro surveillance 25:2000058

Rodo X, Curcoll R, Robinson M, Ballester J, Burns JC, Cayan DR, Lipkin WI, Williams BL, Couto-Rodriguez M, Nakamura Y, Uehara R, Tanimoto H, Morgui JA (2014) Tropospheric winds from northeastern China carry the etiologic agent of Kawasaki disease from its source to Japan. Proc Natl Acad Sci U S A 111:7952–7957

Rogers JP, Chesney E, Oliver D, Pollak TA, McGuire P, Fusar-Poli P, Zandi MS, Lewis G, David AS (2020a) Psychiatric and neuropsychiatric presentations associated with severe coronavirus infections: a systematic review and meta-analysis with comparison to the COVID-19 pandemic. Lancet Psychiatry 7:611–627

Rogers K, Jakes L, Swanson A (2020b) Trump defends using ‘Chinese virus’ label, ignoring growing criticism. The New York Times. https://www.nytimes.com/2020/03/18/us/politics/china-virus.html

Rubens JH, Karakousis PC, Jain SK (2020) Stability and viability of SARS-CoV-2. N Engl J Med 382:1962–1963

Russo M (2020) Up to 5 NY children dead, 100 sickened by rare COVID-related illness. NBC New York. https://www.nbcnewyork.com/investigations/kawasaki-disease-up-to-5-ny-children-dead-85-sickened-by-rare-covid-related-illness/2411571/

Saad M, Omrani AS, Baig K, Bahloul A, Elzein F, Matin MA, Selim MA, Al Mutairi M, Al Nakhli D, Al Aidaroos AY, Al Sherbeeni N, Al-Khashan HI, Memish ZA, Albarrak AM (2014) Clinical aspects and outcomes of 70 patients with Middle East respiratory syndrome coronavirus infection: a single-center experience in Saudi Arabia. Int J Infect Dis 29:301–306

Sanders JM, Monogue ML, Jodlowski TZ, Cutrell JB (2020) Pharmacologic treatments for coronavirus disease 2019 (COVID-19): a review. JAMA

Schlosser E (2020) America’s slaughterhouses Aren’t just killing animals. The Atlantic. https://www.theatlantic.com/ideas/archive/2020/05/essentials-meatpeacking-coronavirus/611437/

Schoeman D, Fielding BC (2019) Coronavirus envelope protein: current knowledge. Virol J 16:69

Schwamm LH, Erskine A, Licurse A (2020) A digital embrace to blunt the curve of COVID19 pandemic. NPJ Digit Med 3:64

Seeman TE (1996) Social ties and health: the benefits of social integration. Ann Epidemiol 6:442–451

Shang J, Ye G, Shi K, Wan Y, Luo C, Aihara H, Geng Q, Auerbach A, Li F (2020) Structural basis of receptor recognition by SARS-CoV-2. Nature 581:221–224

Shen M, Peng Z, Xiao Y, Zhang L (2020) Modelling the epidemic trend of the 2019 novel coronavirus outbreak in China. bioRxiv

Siddamreddy S, Thotakura R, Dandu V, Kanuru S, Meegada S (2020) Corona virus disease 2019 (COVID-19) presenting as acute ST elevation myocardial infarction. Cureus 12:e7782

Singh AK, Bhushan B, Maurya A, Mishra G, Singh SK, Awasthi R (2020) Novel Coronavirus disease 2019 (COVID-19) and neurodegenerative disorders. Dermatol Ther:e13591

Siu YL, Teoh KT, Lo J, Chan CM, Kien F, Escriou N, Tsao SW, Nicholls JM, Altmeyer R, Peiris JS, Bruzzone R, Nal B (2008) The M, E, and N structural proteins of the severe acute respiratory syndrome coronavirus are required for efficient assembly, trafficking, and release of virus-like particles. J Virol 82:11318–11330

Song HC, Seo MY, Stadler K, Yoo BJ, Choo QL, Coates SR, Uematsu Y, Harada T, Greer CE, Polo JM, Pileri P, Eickmann M, Rappuoli R, Abrignani S, Houghton M, Han JH (2004) Synthesis and characterization of a native, oligomeric form of recombinant severe acute respiratory syndrome coronavirus spike glycoprotein. J Virol 78:10328–10335

Song Y, Liu P, Shi XL, Chu YL, Zhang J, Xia J, Gao XZ, Qu T, Wang MY (2020) SARS-CoV-2 induced diarrhoea as onset symptom in patient with COVID-19. Gut 69:1143–1144

Spagnolo JF, Hogue BG (2000) Host protein interactions with the 3′ end of bovine coronavirus RNA and the requirement of the poly(A) tail for coronavirus defective genome replication. J Virol 74:5053–5065

Spychalski P, Błażyńska-Spychalska A, Kobiela J (2020) Estimating case fatality rates of COVID-19. Lancet Infect Dis 20:774–775

Srinivasan S, Cui H, Gao Z, Liu M, Lu S, Mkandawire W, Narykov O, Sun M, Korkin D (2020) Structural genomics of SARS-CoV-2 indicates evolutionary conserved functional regions of viral proteins. Viruses 12:360

Billboard Staff (2020) Here are all the major music events canceled due to coronavirus (updating). Billboard. https://www.billboard.com/articles/business/touring/9323647/concerts-canceled-coronavirus-list

Stancati M, Douglas J (2020) Doctors investigate link between rare childhood disease and Covid-19. The Wall Street Journal https://www.wsj.com/articles/doctors-investigate-link-between-rare-childhood-disease-and-covid-19-11588187103

Su H, Yang M, Wan C, Yi LX, Tang F, Zhu HY, Yi F, Yang HC, Fogo AB, Nie X, Zhang C (2020) Renal histopathological analysis of 26 postmortem findings of patients with COVID-19 in China. Kidney Int 98:219–227

Sui J, Li W, Murakami A, Tamin A, Matthews LJ, Wong SK, Moore MJ, Tallarico AS, Olurinde M, Choe H, Anderson LJ, Bellini WJ, Farzan M, Marasco WA (2004) Potent neutralization of severe acute respiratory syndrome (SARS) coronavirus by a human mAb to S1 protein that blocks receptor association. Proc Natl Acad Sci U S A 101:2536–2541

Sultan S, Altayar O, Siddique SM, Davitkov P, Feuerstein JD, Lim JK, Falck-Ytter Y, El-Serag HB, Aga (2020) AGA Institute rapid review of the GI and liver manifestations of COVID-19, meta-analysis of international data, and recommendations for the Consultative Management of Patients with COVID-19. Gastroenterology

Sun X, Wang T, Cai D, Hu Z, Chen J, Liao H, Zhi L, Wei H, Zhang Z, Qiu Y, Wang J, Wang A (2020) Cytokine storm intervention in the early stages of COVID-19 pneumonia. Cytokine Growth Factor Rev 53:38–42

Tan YW, Hong W, Liu DX (2012) Binding of the 5′-untranslated region of coronavirus RNA to zinc finger CCHC-type and RNA-binding motif 1 enhances viral replication and transcription. Nucleic Acids Res 40:5065–5077

Tang N, Li D, Wang X, Sun Z (2020) Abnormal coagulation parameters are associated with poor prognosis in patients with novel coronavirus pneumonia. J Thromb Haemost 18:844–847

Tao C, Guang C, Wei G, Min X, Marco, Li Y, Suhua CFL (2020) A quick guide to the diagnosis and treatment of pneumonia for novel coronavirus infections (third edition). Herald Med 39:305–307 http://kns.cnki.net/kcms/detail/42.1293.r.20200130.1803.002.html

Tavazzi G, Pellegrini C, Maurelli M, Belliato M, Sciutti F, Bottazzi A, Sepe PA, Resasco T, Camporotondo R, Bruno R, Baldanti F, Paolucci S, Pelenghi S, Iotti GA, Mojoli F, Arbustini E (2020) Myocardial localization of coronavirus in COVID-19 cardiogenic shock. Eur J Heart Fail 22:911–915

Torales J, O'Higgins M, Castaldelli-Maia JM, Ventriglio A (2020) The outbreak of COVID-19 coronavirus and its impact on global mental health. Int J Soc Psychiatry 66:317–320

Toscano G, Palmerini F, Ravaglia S, Ruiz L, Invernizzi P, Cuzzoni MG, Franciotta D, Baldanti F, Daturi R, Postorino P, Cavallini A, Micieli G (2020) Guillain-Barre syndrome associated with SARS-CoV-2. N Engl J Med 382:2574–2576

Tsai J, Wilson M (2020) COVID-19: a potential public health problem for homeless populations. Lancet Public Health 5:e186–e187

U.S. Food and drug Administration (FDA) (2020) Coronavirus (COVID-19) update: FDA issues emergency use authorization for potential COVID-19 treatment. https://www.fda.gov/news-events/press-announcements/coronavirus-covid-19-update-fda-issues-emergency-use-authorization-potential-covid-19-treatment

van Doremalen N, Bushmaker T, Morris DH, Holbrook MG, Gamble A, Williamson BN, Tamin A, Harcourt JL, Thornburg NJ, Gerber SI, Lloyd-Smith JO, de Wit E, Munster VJ (2020) Aerosol and surface stability of SARS-CoV-2 as compared with SARS-CoV-1. N Engl J Med 382:1564–1567

Vandell P (2020) Pinal County sheriff mark lamb responds to testing positive for COVID-19, says he wouldn't enforce mask mandate. Azcentral. https://www.azcentral.com/story/news/local/arizona-breaking/2020/06/20/pinal-county-sheriff-mark-lamb-responds-testing-positive-covid-19-says-he-wouldnt-enforce-mask-manda/3230614001/

Verheije MH, Raaben M, Mari M, Te Lintelo EG, Reggiori F, van Kuppeveld FJ, Rottier PJ, de Haan CA (2008) Mouse hepatitis coronavirus RNA replication depends on GBF1-mediated ARF1 activation. PLoS Pathog 4:e1000088

Volz E et al (2020) Report 5: phylogenetic analysis of SARS-CoV-2. Imperial College London. Imperial College London COVID-19. https://doi.org/10.25561/77169

Vulture editors (2020) All the live events, movie releases, and productions affected by the Coronavirus. Vulture. https://www.vulture.com/2020/06/events-cancelled-coronavirus.html

Walls AC, Park YJ, Tortorici MA, Wall A, McGuire AT, Veesler D (2020) Structure, function, and antigenicity of the SARS-CoV-2 spike glycoprotein. Cell 181:281–292

Wan Y, Shang J, Graham R, Baric RS, Li F (2020) Receptor recognition by the Novel coronavirus from Wuhan: an analysis based on decade-Long structural studies of SARS coronavirus. J Virol 94:e00127–e00120

Wang J, Fang S, Xiao H, Chen B, Tam JP, Liu DX (2009) Interaction of the coronavirus infectious bronchitis virus membrane protein with beta-actin and its implication in virion assembly and budding. PLoS One 4:e4908

Wang D, Hu B, Hu C, Zhu F, Liu X, Zhang J, Wang B, Xiang H, Cheng Z, Xiong Y, Zhao Y, Li Y, Wang X, Peng Z (2020a) Clinical characteristics of 138 hospitalized patients with 2019 Novel Coronavirus-infected pneumonia in Wuhan, China. JAMA 323:1061–1069

Wang Q, Zhang Y, Wu L, Niu S, Song C, Zhang Z, Lu G, Qiao C, Hu Y, Yuen KY, Wang Q, Zhou H, Yan J, Qi J (2020b) Structural and functional basis of SARS-CoV-2 entry by using human ACE2. Cell 181:894–904

Wang W, Tang J, Wei F (2020c) Updated understanding of the outbreak of 2019 novel coronavirus (2019-nCoV) in Wuhan, China. J Med Virol 92:441–447

Wertheim JO, Chu DK, Peiris JS, Kosakovsky Pond SL, Poon LL (2013) A case for the ancient origin of coronaviruses. J Virol 87:7039–7045

Wong ACP, Li X, Lau SKP, Woo PCY (2019) Global epidemiology of bat coronaviruses. Viruses 11:174

Woo PC, Huang Y, Lau SK, Yuen KY (2010) Coronavirus genomics and bioinformatics analysis. Viruses 2:1804–1820

World Health Organization (2003) Summary of probable SARS cases with onset of illness from 1 November 2002 to 31 July 2003. https://www.who.int/csr/sars/country/table2004_04_21/en/

World Health Organization (2019) MERS situation update, December 2019. Epidemic and pandemic-prone diseases. http://www.emro.who.int/pandemic-epidemic-diseases/mers-cov/mers-situation-update-december-2019.html

World Health Organization (2020a) Coronavirus disease (COVID-2019) situation reports. https://www.who.int/emergencies/diseases/novel-coronavirus-2019/situation-reports/

World Health Organization (2020b) Laboratory testing for coronavirus disease 2019 (COVID-19) in suspected human cases: interim guidance, 2 March 2020. https://apps.who.int/iris/handle/10665/331329

World Health Organization (2020c) WHO Timeline-COVID-19. https://www.who.int/news-room/detail/27-04-2020-who-timeline%2D%2D-covid-19

World Health Organization (2020d) Novel Coronavirus – China. Emergencies preparedness, response. https://www.who.int/csr/don/12-january-2020-novel-coronavirus-china/en/

World Health Organization (2020e) Novel Coronavirus – Thailand (ex-China). Emergencies preparedness, response. https://www.who.int/csr/don/14-january-2020-novel-coronavirus-thailand/en/

World Health Organization (2020f) Novel Coronavirus(2019-nCoV) Situation Report-10. https://www.who.int/docs/default-source/coronaviruse/situation-reports/20200130-sitrep-10-ncov.pdf?sfvrsn=d0b2e480_2

World Health Organization (2020g) Novel Coronavirus(2019-nCoV) Situation Report–20. https://www.who.int/docs/default-source/coronaviruse/situation-reports/20200209-sitrep-20-ncov.pdf?sfvrsn=6f80d1b9_4

World Health Organization (2020h) Naming the coronavirus disease (COVID-19) and the virus that causes it. https://www.who.int/emergencies/diseases/novel-coronavirus-2019/technical-guidance/naming-the-coronavirus-disease-(covid-2019)-and-the-virus-that-causes-it

World Health Organization (2020i) Coronavirus disease 2019 (COVID-19) Situation Report–26. https://www.who.int/docs/default-source/coronaviruse/situation-reports/20200215-sitrep-26-covid-19.pdf?sfvrsn=a4cc6787_2

World Health Organization (2020j) Coronavirus disease 2019 (COVID-19) Situation Report–40. https://www.who.int/docs/default-source/coronaviruse/situation-reports/20200229-sitrep-40-covid-19.pdf?sfvrsn=849d0665_2

World Health Organization (2020k) Coronavirus disease 2019 (COVID-19) Situation Report–51. https://www.who.int/docs/default-source/coronaviruse/situation-reports/20200311-sitrep-51-covid-19.pdf?sfvrsn=1ba62e57_10

World Health Organization (2020l) Coronavirus disease 2019 (COVID-19) Situation Report–59. https://www.who.int/docs/default-source/coronaviruse/situation-reports/20200319-sitrep-59-covid-19.pdf?sfvrsn=c3dcdef9_2

World Health Organization (2020m) Coronavirus disease 2019 (COVID-19) Situation Report–62. https://www.who.int/docs/default-source/coronaviruse/situation-reports/20200322-sitrep-62-covid-19.pdf?sfvrsn=755c76cd_2

World Health Organization (2020n) Coronavirus disease 2019 (COVID-19) Situation Report–67. https://www.who.int/docs/default-source/coronaviruse/situation-reports/20200327-sitrep-67-covid-19.pdf?sfvrsn=b65f68eb_4

World Health Organization (2020o) Coronavirus disease 2019 (COVID-19) Situation Report–69. https://www.who.int/docs/default-source/coronaviruse/situation-reports/20200329-sitrep-69-covid-19.pdf?sfvrsn=8d6620fa_8

World Health Organization (2020p) Coronavirus disease 2019 (COVID-19) Situation Report–72. https://www.who.int/docs/default-source/coronaviruse/situation-reports/20200401-sitrep-72-covid-19.pdf?sfvrsn=3dd8971b_2

World Health Organization (2020q) Coronavirus disease 2019 (COVID-19) Situation Report–76. https://www.who.int/docs/default-source/coronaviruse/situation-reports/20200405-sitrep-76-covid-19.pdf?sfvrsn=6ecf0977_4

World Health Organization (2020r) Coronavirus disease 2019 (COVID-19) Situation Report–86. https://www.who.int/docs/default-source/coronaviruse/situation-reports/20200415-sitrep-86-covid-19.pdf?sfvrsn=c615ea20_6

World Health Organization (2020s) Coronavirus disease 2019 (COVID-19) Situation Report–96. https://www.who.int/docs/default-source/coronaviruse/situation-reports/20200425-sitrep-96-covid-19.pdf?sfvrsn=a33836bb_4

World Health Organization (2020t) Coronavirus disease 2019 (COVID-19) Situation Report–98. https://www.who.int/docs/default-source/coronaviruse/situation-reports/20200427-sitrep-98-covid-19.pdf?sfvrsn=90323472_4

World Health Organization (2020u) Coronavirus disease (COVID-19) Situation Report–126. https://www.who.int/docs/default-source/coronaviruse/situation-reports/20200525-covid-19-sitrep-126.pdf?sfvrsn=887dbd66_2

World Health Organization (2020v) Coronavirus disease (COVID-19) Situation Report–128. https://www.who.int/docs/default-source/coronaviruse/situation-reports/20200527-covid-19-sitrep-128.pdf?sfvrsn=11720c0a_2

World Health Organization (2020w) Coronavirus disease (COVID-19) advice for the public. https://www.who.int/emergencies/diseases/novel-coronavirus-2019/advice-for-public

Worldometer (2020a) COVID-19 CORONAVIRUS PANDEMIC. https://www.worldometers.info/coronavirus/

Worldometer (2020b) Coronavirus Cases: Itely. https://www.worldometers.info/coronavirus/country/italy/.

Worldometer (2020c) Coronavirus Cases: United States. https://www.worldometers.info/coronavirus/country/us/

Worldometer (2020d) Coronavirus Cases: Spain. https://www.worldometers.info/coronavirus/country/spain/

Worldometer (2020e) Coronavirus Cases: UK. https://www.worldometers.info/coronavirus/country/uk/

Wrapp D, Wang N, Corbett KS, Goldsmith JA, Hsieh CL, Abiona O, Graham BS, McLellan JS (2020) Cryo-EM structure of the 2019-nCoV spike in the prefusion conformation. Science 367:1260–1263

Wu CH, Yeh SH, Tsay YG, Shieh YH, Kao CL, Chen YS, Wang SH, Kuo TJ, Chen DS, Chen PJ (2009) Glycogen synthase kinase-3 regulates the phosphorylation of severe acute respiratory syndrome coronavirus nucleocapsid protein and viral replication. J Biol Chem 284:5229–5239

Wu CH, Chen PJ, Yeh SH (2014) Nucleocapsid phosphorylation and RNA helicase DDX1 recruitment enables coronavirus transition from discontinuous to continuous transcription. Cell Host Microbe 16:462–472

Wu C, Liu Y, Yang Y, Zhang P, Zhong W, Wang Y, Wang Q, Xu Y, Li M, Li X, Zheng M, Chen L, Li H (2020a) Analysis of therapeutic targets for SARS-CoV-2 and discovery of potential drugs by computational methods. Acta Pharm Sin B 10:766–788

Wu JT, Leung K, Leung GM (2020b) Nowcasting and forecasting the potential domestic and international spread of the 2019-nCoV outbreak originating in Wuhan, China: a modelling study. Lancet 395:689–697

Wu R, Wang L, Kuo HD, Shannar A, Peter R, Chou PJ, Li S, Hudlikar R, Liu X, Liu Z, Poiani GJ, Amorosa L, Brunetti L, Kong AN (2020c) An update on current therapeutic drugs treating COVID-19. Curr Pharmacol Rep:1–15

Xiao F, Sun J, Xu Y, Li F, Huang X, Li H, Zhao J, Huang J, Zhao J (2020) Infectious SARS-CoV-2 in feces of patient with severe COVID-19. Emerg Infect Dis 26

Xu S, Li Y (2020) Beware of the second wave of COVID-19. Lancet 395:1321–1322

Xu X, Liu Y, Weiss S, Arnold E, Sarafianos SG, Ding J (2003) Molecular model of SARS coronavirus polymerase: implications for biochemical functions and drug design. Nucleic Acids Res 31:7117–7130

Yamin M (2020) Counting the cost of COVID-19. Int J Inf Technol:1–7

Yan R, Zhang Y, Li Y, Xia L, Guo Y, Zhou Q (2020) Structural basis for the recognition of SARS-CoV-2 by full-length human ACE2. Science 367:1444–1448

Yancy CW (2020) COVID-19 and African Americans. JAMA

Yang X, Yu Y, Xu J, Shu H, Xia J, Liu H, Wu Y, Zhang L, Yu Z, Fang M, Yu T, Wang Y, Pan S, Zou X, Yuan S, Shang Y (2020) Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study. Lancet Respir Med 8:475–481

Ye G, Lin H, Chen S, Wang S, Zeng Z, Wang W, Zhang S, Rebmann T, Li Y, Pan Z, Yang Z, Wang Y, Wang F, Qian Z, Wang X (2020a) Environmental contamination of SARS-CoV-2 in healthcare premises. J Inf Secur

Ye ZW, Yuan S, Yuen KS, Fung SY, Chan CP, Jin DY (2020b) Zoonotic origins of human coronaviruses. Int J Biol Sci 16:1686–1697

Yuki K, Fujiogi M, Koutsogiannaki S (2020) COVID-19 pathophysiology: a review. Clin Immunol 215:108427

Zaki AM, van Boheemen S, Bestebroer TM, Osterhaus AD, Fouchier RA (2012) Isolation of a novel coronavirus from a man with pneumonia in Saudi Arabia. N Engl J Med 367:1814–1820

Zeng JH, Liu YX, Yuan J, Wang FX, Wu WB, Li JX, Wang LF, Gao H, Wang Y, Dong CF, Li YJ, Xie XJ, Feng C, Liu L (2020) First case of COVID-19 complicated with fulminant myocarditis: a case report and insights. Infection

Zhang X, Shi H, Chen J, Shi D, Dong H, Feng L (2015) Identification of the interaction between vimentin and nucleocapsid protein of transmissible gastroenteritis virus. Virus Res 200:56–63

Zhang SF, Tuo JL, Huang XB, Zhu X, Zhang DM, Zhou K, Yuan L, Luo HJ, Zheng BJ, Yuen KY, Li MF, Cao KY, Xu L (2018) Epidemiology characteristics of human coronaviruses in patients with respiratory infection symptoms and phylogenetic analysis of HCoV-OC43 during 2010-2015 in Guangzhou. PLoS One 13:e0191789

Zhang B, Zhou X, Zhu C, Feng F, Qiu Y, Feng J, Jia Q, Song Q, Zhu B, Wang J (2020a) Immune phenotyping based on neutrophil-to-lymphocyte ratio and IgG predicts disease severity and outcome for patients with COVID-19. medRxiv

Zhang C, Wu Z, Li J-W, Zhao H, Wang G-Q (2020b) The cytokine release syndrome (CRS) of severe COVID-19 and Interleukin-6 receptor (IL-6R) antagonist tocilizumab may be the key to reduce the mortality. Int J Antimicrob Agents 55:105954–105954

Zhang L, Lin D, Sun X, Curth U, Drosten C, Sauerhering L, Becker S, Rox K, Hilgenfeld R (2020c) Crystal structure of SARS-CoV-2 main protease provides a basis for design of improved alpha-ketoamide inhibitors. Science 368:409–412

Zhang W, Du RH, Li B, Zheng XS, Yang XL, Hu B, Wang YY, Xiao GF, Yan B, Shi ZL, Zhou P (2020d) Molecular and serological investigation of 2019-nCoV infected patients: implication of multiple shedding routes. Emerg Microbes Infect 9:386–389

Zhao H, Shen D, Zhou H, Liu J, Chen S (2020) Guillain-Barre syndrome associated with SARS-CoV-2 infection: causality or coincidence? Lancet Neurol 19:383–384

Zheng J, Yamada Y, Fung TS, Huang M, Chia R, Liu DX (2018) Identification of N-linked glycosylation sites in the spike protein and their functional impact on the replication and infectivity of coronavirus infectious bronchitis virus in cell culture. Virology 513:65–74

Zhong R (2020) The Coronavirus exposes education’s digital divide. The New York Times. https://www.nytimes.com/2020/03/17/technology/china-schools-coronavirus.html

Zhou B, She J, Wang Y, Ma X (2020a) A case of coronavirus disease 2019 with concomitant acute cerebral infarction and deep vein thrombosis. Front Neurol 11:296

Zhou F, Yu T, Du R, Fan G, Liu Y, Liu Z, Xiang J, Wang Y, Song B, Gu X, Guan L, Wei Y, Li H, Wu X, Xu J, Tu S, Zhang Y, Chen H, Cao B (2020b) Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet 395:1054–1062

Zhou P et al (2020c) A pneumonia outbreak associated with a new coronavirus of probable bat origin. Nature 579:270–273

Zhou Y, Hou Y, Shen J, Huang Y, Martin W, Cheng F (2020d) Network-based drug repurposing for novel coronavirus 2019-nCoV/SARS-CoV-2. Cell Discov 6:14

Zhu H, Wei L, Niu P (2020a) The novel coronavirus outbreak in Wuhan, China. Glob Health Res Policy 5:6

Zhu N, Zhang D, Wang W, Li X, Yang B, Song J, Zhao X, Huang B, Shi W, Lu R, Niu P, Zhan F, Ma X, Wang D, Xu W, Wu G, Gao GF, Tan W, China Novel Coronavirus I, Research T (2020b) A Novel Coronavirus from patients with pneumonia in China, 2019. N Engl J Med 382:727–733

Ziebuhr J (2005) In: Enjuanes L (ed) Coronavirus replication and reverse genetics, pp 57–94

Ziebuhr J, Snijder EJ, Gorbalenya AE (2000) Virus-encoded proteinases and proteolytic processing in the Nidovirales. J Gen Virol 81:853–879

Zumla A, Chan JF, Azhar EI, Hui DS, Yuen KY (2016) Coronaviruses - drug discovery and therapeutic options. Nat Rev Drug Discov 15:327–347

Zuniga S, Sola I, Moreno JL, Sabella P, Plana-Duran J, Enjuanes L (2007) Coronavirus nucleocapsid protein is an RNA chaperone. Virology 357:215–227

Zuniga S, Cruz JL, Sola I, Mateos-Gomez PA, Palacio L, Enjuanes L (2010) Coronavirus nucleocapsid protein facilitates template switching and is required for efficient transcription. J Virol 84:2169–2175